Companies Dominating the Atropine Sulfate Landscape
- Meridian Medical Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Novartis AG
- Teligent
- C²PHARMA
- RESONANCE LABORATORIES
- China Resources Double-crane Pharmaceutical Co., Ltd.
- Albany Molecular Research Inc.
- Alchem International Pvt. Ltd.
- Saurav Chemicals Ltd.
- Wuhan senwayer century chemical Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of atropine sulfate is assessed at USD 110.56 million.
Atropine Sulfate Market size was valued at USD 106.23 million in 2024 and is expected to reach USD 195.41 million by 2037, expanding at around 4.8% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to dominate majority revenue share by 2037, propelled by presence of some of the key players that are also traditional suppliers of medicinal drugs.
The major players in the market are Meridian Medical Technologies, Inc., Novartis AG, Teligent, C²PHARMA, RESONANCE LABORATORIES, China Resources Double-crane Pharmaceutical Co., Ltd., Albany Molecular Research Inc., Alchem International Pvt. Ltd., Saurav Chemicals Ltd., Wuhan senwayer century chemical Co., Ltd., and others.
